- Disease: Post-COVID-19
- Study type: Observational Cohort Study
- Study type descriptors: Cohort study, Observational, Single centre
- Study aim: To evaluate the efficacy and safety of lecithin-based formulations of Curcuma longa and Boswellia serrata extracts in treating gastrointestinal symptoms in patients with post-acute COVID-19 irritable bowel syndrome and irritable bowel syndrome without prior COVID-19 infection
- Number of participants enrolled: 44
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- General population
- Elderly
- Adult
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Dietary
- Lifestyle intervention
- Curcuma
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to